Homology Medicines, Inc.

We are mission-focused on developing
one-time treatments for genetic disorders

We are partners to the

rare disease community

Learn about our Clinical Trials >>>

We Are Applying our Broad Genetic Medicines

Platform to Treat, or Cure, Genetic Disease

Learn About Our Platform >>> View Our Pipeline >>>

Recent News >>>


January 4, 2023

Homology Medicines Provides Update on pheEDIT and juMPStart Clinical Trials and Announces Expected 2023 Milestones, Including Initial Data Read-Outs from Both Programs

November 10, 2022

Homology Medicines Reports Third Quarter 2022 Financial Results and Recent Highlights

October 27, 2022

Homology Medicines Presents on Design of pheEDIT Trial Evaluating One-Time Nuclease-Free Gene Editing Candidate HMI-103 for PKU at American Society of Human Genetics Meeting

We are

Homology

Learn about our Team and Mission >>>

Homology employee activities Homology employee activities
Homology employee activities Homology employee activities
Homology employee activities Homology employee activities
Homology Logo
  • We are Homology
    • We Are Homology
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Technology Platform
    • AAVHSC Platform
    • Gene Therapy
    • Gene Editing
    • GTx-mAb
    • Publications and Presentations
  • Pipeline
  • Patients & Families
    • Community Involvement
    • Patient Stories
    • Expanded Access Policy
  • Clinical Trials
    • Overview
    • Gene Editing Clinical Trial for PKU
    • Gene Therapy Clinical Trial for MPS II
  • Culture & Careers
  • Investors
    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Stock Calculator
    • News & Events
      • News Releases
      • Investor Calendar
      • Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Email Alerts
      • Contact IR
  • Culture & Careers
  • Contact Us

© Copyright 2023 Homology Medicines, Inc. All rights reserved.

  • Terms of Use
  • Accessibility Statement
MENU
  • We are Homology
    • We Are Homology
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Technology Platform
    • AAVHSC Platform
    • Gene Therapy
    • Gene Editing
    • GTx-mAb
    • Publications and Presentations
  • Pipeline
  • Patients & Families
    • Community Involvement
    • Patient Stories
    • Expanded Access Policy
  • Clinical Trials
    • Overview
    • Gene Editing Clinical Trial for PKU
    • Gene Therapy Clinical Trial for MPS II
  • Culture & Careers
  • Investors
    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Stock Calculator
    • News & Events
      • News Releases
      • Investor Calendar
      • Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Email Alerts
      • Contact IR